Warning: The NCBI web site requires JavaScript to function. more...
Why don't health workers prescribe ACT? A qualitative study of factors affecting the prescription of artemether-lumefantrine.
Wasunna B, Zurovac D, Goodman CA, Snow RW.
Malar J. 2008 Feb 5;7:29.
Related citations
Translation of artemether-lumefantrine treatment policy into paediatric clinical practice: an early experience from Kenya.
Zurovac D, Njogu J, Akhwale W, Hamer DH, Snow RW.
Trop Med Int Health. 2008 Jan;13(1):99-107.
Malaria case-management under artemether-lumefantrine treatment policy in Uganda.
Zurovac D, Tibenderana JK, Nankabirwa J, Ssekitooleko J, Njogu JN, Rwakimari JB, Meek S, Talisuna A, Snow RW.
Malar J. 2008 Sep 19;7:181.
Adherence to prescribed artemisinin-based combination therapy in Garissa and Bunyala districts, Kenya.
Lawford H, Zurovac D, O'Reilly L, Hoibak S, Cowley A, Munga S, Vulule J, Juma E, Snow RW, Allan R.
Malar J. 2011 Sep 23;10:281.
The effect of mobile phone text-message reminders on Kenyan health workers' adherence to malaria treatment guidelines: a cluster randomised trial.
Zurovac D, Sudoi RK, Akhwale WS, Ndiritu M, Hamer DH, Rowe AK, Snow RW.
Lancet. 2011 Aug 27;378(9793):795-803. Epub 2011 Aug 3.
A qualitative study of the feasibility and community perception on the effectiveness of artemether-lumefantrine use in the context of home management of malaria in south-west Nigeria.
Ajayi IO, Falade CO, Olley BO, Yusuf B, Gbotosho S, Iyiola T, Olaniyan O, Happi C, Munguti K, Pagnoni F.
BMC Health Serv Res. 2008 Jun 1;8:119.
Health facility and health worker readiness to deliver new national treatment policy for malaria in Kenya.
Njogu J, Akhwale W, Hamer DH, Zurovac D.
East Afr Med J. 2008 May;85(5):213-21.
Paediatric malaria case-management with artemether-lumefantrine in Zambia: a repeat cross-sectional study.
Zurovac D, Ndhlovu M, Sipilanyambe N, Chanda P, Hamer DH, Simon JL, Snow RW.
Malar J. 2007 Mar 16;6:31.
The use of artemether-lumefantrine by febrile children following national implementation of a revised drug policy in Kenya.
Gitonga CW, Amin AA, Ajanga A, Kangwana BB, Noor AM, Snow RW.
Trop Med Int Health. 2008 Apr;13(4):487-94. Epub 2008 Feb 22.
The challenges of changing national malaria drug policy to artemisinin-based combinations in Kenya.
Amin AA, Zurovac D, Kangwana BB, Greenfield J, Otieno DN, Akhwale WS, Snow RW.
Malar J. 2007 May 29;6:72.
Effect of malaria rapid diagnostic tests on the management of uncomplicated malaria with artemether-lumefantrine in Kenya: a cluster randomized trial.
Skarbinski J, Ouma PO, Causer LM, Kariuki SK, Barnwell JW, Alaii JA, de Oliveira AM, Zurovac D, Larson BA, Snow RW, Rowe AK, Laserson KF, Akhwale WS, Slutsker L, Hamel MJ.
Am J Trop Med Hyg. 2009 Jun;80(6):919-26.
Predictors of the quality of health worker treatment practices for uncomplicated malaria at government health facilities in Kenya.
Zurovac D, Rowe AK, Ochola SA, Noor AM, Midia B, English M, Snow RW.
Int J Epidemiol. 2004 Oct;33(5):1080-91. Epub 2004 Jul 15.
Effect of artemether-lumefantrine policy and improved vector control on malaria burden in KwaZulu-Natal, South Africa.
Barnes KI, Durrheim DN, Little F, Jackson A, Mehta U, Allen E, Dlamini SS, Tsoka J, Bredenkamp B, Mthembu DJ, White NJ, Sharp BL.
PLoS Med. 2005 Nov;2(11):e330. Epub 2005 Oct 4.
Health workers perceptions on chloroquine and sulfadoxine/sulfalene pyrimethamine monotherapies: implications for the change to combination therapy of artemether/lumefantrine in Tanzania.
Tarimo DS, Malekela DA.
East Afr J Public Health. 2007 Apr;4(1):43-6.
Therapeutic efficacy of artemether-lumefantrine in uncomplicated falciparum malaria in India.
Valecha N, Srivastava P, Mohanty SS, Mittra P, Sharma SK, Tyagi PK, Pradhan K, Dev V, Singh R, Dash AP, Sharma YD.
Malar J. 2009 May 19;8:107.
A randomized, open-label, comparative efficacy trial of artemether-lumefantrine suspension versus artemether-lumefantrine tablets for treatment of uncomplicated Plasmodium falciparum malaria in children in western Kenya.
Juma EA, Obonyo CO, Akhwale WS, Ogutu BR.
Malar J. 2008 Dec 22;7:262.
Simple field assays to check quality of current artemisinin-based antimalarial combination formulations.
Ioset JR, Kaur H.
PLoS One. 2009 Sep 30;4(9):e7270.
Knowledge and malaria treatment practices using artemisinin combination therapy (ACT) in Malawi: survey of health professionals.
Kalilani-Phiri LV, Lungu D, Coghlan R.
Malar J. 2011 Sep 22;10:279.
Adherence to a six-dose regimen of artemether-lumefantrine for treatment of uncomplicated Plasmodium falciparum malaria in Uganda.
Fogg C, Bajunirwe F, Piola P, Biraro S, Checchi F, Kiguli J, Namiiro P, Musabe J, Kyomugisha A, Guthmann JP.
Am J Trop Med Hyg. 2004 Nov;71(5):525-30.
Randomized, multicentre assessment of the efficacy and safety of ASAQ--a fixed-dose artesunate-amodiaquine combination therapy in the treatment of uncomplicated Plasmodium falciparum malaria.
Ndiaye JL, Randrianarivelojosia M, Sagara I, Brasseur P, Ndiaye I, Faye B, Randrianasolo L, Ratsimbasoa A, Forlemu D, Moor VA, Traore A, Dicko Y, Dara N, Lameyre V, Diallo M, Djimde A, Same-Ekobo A, Gaye O.
Malar J. 2009 Jun 8;8:125.
Filter your results:
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on